Related Experiment Video
Updated: Aug 14, 2026

08:51
Data Acquisition and Analysis In Brainstem Evoked Response Audiometry In Mice
Published on: May 10, 2019
[Changes in early auditory evoked potentials in acoustic neuroma]
1Universitäts-HNO-Klinik Heidelberg.
HNO
|September 1, 1991
Summary
Auditory brain-stem responses (ABRs) effectively diagnose acoustic neuromas by identifying prolonged central conduction times. These ABR findings aid in differentiating retrocochlear from cochlear lesions.
Area of Science:
- Neuroscience
- Audiology
- Medical Imaging
Context:
- Acoustic neuromas (ANs) are tumors affecting the auditory nerve.
- Accurate diagnosis of ANs is crucial for timely intervention and management.
- Distinguishing ANs from cochlear pathologies requires sensitive diagnostic tools.
Purpose:
- To evaluate the diagnostic utility of auditory brain-stem responses (ABRs) in patients with acoustic neuroma.
- To compare ABR characteristics between patients with ANs and control groups, including those with cochlear pathologies.
- To identify specific ABR parameters and critical values for differentiating retrocochlear from cochlear hearing loss.
Summary:
- Auditory brain-stem responses (ABRs) in 38 acoustic neuroma (AN) patients showed significantly prolonged central conduction time (J1-J5 latency difference) compared to controls.
- A critical value of 4.3 ms for central conduction time demonstrated 90% sensitivity and specificity in separating retrocochlear from cochlear lesions.
- Interaural differences in central conduction time and J5 latency, when corrected for hearing loss, are valuable indicators of ANs, with critical values of 0.3 ms and 0.5 ms, respectively.
Impact:
- Establishes ABRs, particularly central conduction time and interaural differences, as a powerful, non-invasive tool for diagnosing acoustic neuromas.
- Provides specific quantitative criteria (e.g., critical values) to enhance the accuracy of ABR in differentiating retrocochlear disorders.
- Highlights the combined evaluation of multiple ABR features, including waveform morphology and threshold differences, for optimizing diagnostic efficacy, while acknowledging limitations of false positives/negatives.

